PD-L1 regulates the development, maintenance, and function of induced regulatory T cells

被引:1639
作者
Francisco, Loise M. [1 ,2 ]
Salinas, Victor H. [4 ]
Brown, Keturah E. [1 ]
Vanguri, Vijay K. [1 ,2 ]
Freeman, Gordon J. [5 ]
Kuchroo, Vijay K. [3 ]
Sharpe, Arlene H. [1 ,2 ]
机构
[1] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA
[3] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA
[4] Harvard Univ, Cambridge, MA 02138 USA
[5] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
TRANSCRIPTION FACTOR FOXP3; PROGRAMMED DEATH-1 LIGAND-1; GASTRIC EPITHELIAL-CELLS; CUTTING EDGE; DE-NOVO; CLINICAL-SIGNIFICANCE; TUMOR-IMMUNOTHERAPY; SUPPRESSOR FUNCTION; B7-H1; EXPRESSION; IMMUNE EVASION;
D O I
10.1084/jem.20090847
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Both the programmed death (PD) 1-PD-ligand (PD-L) pathway and regulatory T (T reg) cells are instrumental to the maintenance of peripheral tolerance. We demonstrate that PD-L1 has a pivotal role in regulating induced T reg (iT reg) cell development and sustaining iT reg cell function. PD-L1(-/-) antigen-presenting cells minimally convert naive CD4 T cells to iT reg cells, showing the essential role of PD-L1 for iT reg cell induction. PD-L1-coated beads induce iT reg cells in vitro, indicating that PD-L1 itself regulates iT reg cell development. Furthermore, PD-L1 enhances and sustains Foxp3 expression and the suppressive function of iT reg cells. The obligatory role for PD-L1 in controlling iT reg cell development and function in vivo is illustrated by a marked reduction in iT reg cell conversion and rapid onset of a fatal inflammatory phenotype in PD-L1(-/-)PD-L2(-/-)Rag(-/-) recipients of naive CD4 T cells. PD-L1 iT reg cell development is mediated through the down-regulation of phospho-Akt, mTOR, S6, and ERK2 and concomitant with the up-regulation of PTEN, all key signaling molecules which are critical for iT reg cell development. Thus, PD-L1 can inhibit T cell responses by promoting both the induction and maintenance of iT reg cells. These studies define a novel mechanism for iT reg cell development and function, as well as a new strategy for controlling T reg cell plasticity.
引用
收藏
页码:3015 / 3029
页数:15
相关论文
共 78 条
[1]   Activation of MAP kinase p38 is critical for the cell-cycle-controlled suppressor function of regulatory T cells [J].
Adler, Henric S. ;
Kubsch, Sebastian ;
Graulich, Edith ;
Ludwig, Stephan ;
Knop, Juergen ;
Steinbrink, Kerstin .
BLOOD, 2007, 109 (10) :4351-4359
[2]  
Baecher-Allan Clare, 2003, Novartis Found Symp, V252, P67
[3]  
BAECHERALLAN C, 2003, NOVART FDN SYMP, V252, P106, DOI DOI 10.1002/0470871628.CH6
[4]  
BAECHERALLAN C, 2003, NOVART FDN SYMP, V252, P88, DOI DOI 10.1002/0470871628.CH6
[5]   Restoring function in exhausted CD8 T cells during chronic viral infection [J].
Barber, DL ;
Wherry, EJ ;
Masopust, D ;
Zhu, BG ;
Allison, JP ;
Sharpe, AH ;
Freeman, GJ ;
Ahmed, R .
NATURE, 2006, 439 (7077) :682-687
[6]   Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients [J].
Battaglia, Manuela ;
Stabilini, Angela ;
Migliavacca, Barbara ;
Horejs-Hoeck, Jutta ;
Kaupper, Thomas ;
Roncarolo, Maria-Grazia .
JOURNAL OF IMMUNOLOGY, 2006, 177 (12) :8338-8347
[7]   Role of Foxp3-positive regulatory T cells during infection [J].
Belkaid, Yasmine .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2008, 38 (04) :918-921
[8]   Expression of the programmed death ligand 1, b7-h1,on gastric epithelial cells after Helicobacter pylori exposure promotes development of CD4+ CD25+ FoxP3+ regulatory T cells [J].
Beswick, Ellen J. ;
Pinchuk, Irina V. ;
Das, Sournita ;
Powell, Don W. ;
Reyes, Victor E. .
INFECTION AND IMMUNITY, 2007, 75 (09) :4334-4341
[9]   Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis [J].
Bettelli, E ;
Pagany, M ;
Weiner, HL ;
Linington, C ;
Sobel, RA ;
Kuchroo, AK .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (09) :1073-1081
[10]  
Betti M, 2006, ANN ONCOL, V17, P235